Circulating Small Non-coding RNA Signature in Head and Neck Squamous Cell Carcinoma

Overview

Journal Oncotarget

Specialty Oncology

Date 2015 Jun 10

PMID 26057471

Citations 69

Authors

Berta Victoria Martinez

Joseph M Dhahbi

Yury O Nunez Lopez

Katarzyna Lamperska

Pawel Golusinski

Lukasz Luczewski

Tomasz Kolenda

Hani Atamna

Stephen R Spindler

Wojciech Golusinski

Michal M Masternak

Affiliations

Soon will be listed here.

Abstract

The Head and Neck Squamous Cell Carcinoma (HNSCC) is the sixth most common human cancer, causing 350,000 individuals die worldwide each year. The overall prognosis in HNSCC patients has not significantly changed for the last decade. Complete understanding of the molecular mechanisms in HNSCC carcinogenesis could allow an earlier diagnosis and the use of more specific and effective therapies. In the present study we used deep sequencing to characterize small non-coding RNAs (sncRNAs) in serum from HNSCC patients and healthy donors. We identified, for the first time, a multi-marker signature of 3 major classes of circulating sncRNAs in HNSCC, revealing the presence of circulating novel and known miRNAs, and tRNA- and YRNA-derived small RNAs that were significantly deregulated in the sera of HNSCC patients compared to healthy controls. By implementing a triple-filtering approach we identified a subset of highly biologically relevant miRNA-mRNA interactions and we demonstrated that the same genes/pathways affected by somatic mutations in cancer are affected by changes in the abundance of miRNAs. Therefore, one important conclusion from our work is that during cancer development, there seems to be a convergence of oncogenic processes driven by somatic mutations and/or miRNA regulation affecting key cellular pathways.

Citing Articles

The microRNA-6510 as a potential tumor suppressor in head and neck cancer.

Sobecka-Giel A, Ostrowska K, Golusinski W, Suchorska W, Masternak M, Golusinski P Sci Rep. 2025; 15(1):5830.

PMID: 39966442 PMC: 11836324. DOI: 10.1038/s41598-025-86796-0.

YRNAs: biosynthesis, structure, functions and involvment in cancer development.

Campo A, Aliquo F, Velletri T, Campo S Discov Oncol. 2025; 16(1):176.

PMID: 39945971 PMC: 11825425. DOI: 10.1007/s12672-025-01957-x.

tsRNA in head and neck tumors: Opportunities and challenges in the field.

Wu Z, Xu Y, Zhou C, Zhang Y, Chen J Noncoding RNA Res. 2024; 10:223-230.

PMID: 39468996 PMC: 11513501. DOI: 10.1016/j.ncrna.2024.10.003.

Evaluating Circulating Biomarkers for Diagnosis, Prognosis, and Tumor Monitoring in Pediatric Sarcomas: Recent Advances and Future Directions.

Maqueda J, De Feo A, Scotlandi K Biomolecules. 2024; 14(10).

PMID: 39456239 PMC: 11506719. DOI: 10.3390/biom14101306.

Early life interventions metformin and trodusquemine metabolically reprogram the developing mouse liver through transcriptomic alterations.

Ashiqueali S, Schneider A, Zhu X, Juszczyk E, Mansoor M, Zhu Y Aging Cell. 2024; 23(9):e14227.

PMID: 38798180 PMC: 11488326. DOI: 10.1111/acel.14227.

References

Dhahbi J, Spindler S, Atamna H, Yamakawa A, Boffelli D, Mote P . 5' tRNA halves are present as abundant complexes in serum, concentrated in blood cells, and modulated by aging and calorie restriction. BMC Genomics. 2013; 14:298. PMC: 3654920. DOI: 10.1186/1471-2164-14-298. View

Schneider C, Setty M, Holmes A, Maute R, Leslie C, Mussolin L . MicroRNA 28 controls cell proliferation and is down-regulated in B-cell lymphomas. Proc Natl Acad Sci U S A. 2014; 111(22):8185-90. PMC: 4050621. DOI: 10.1073/pnas.1322466111. View

Duan Y, Zhou B, Su H, Liu Y, Du C . miR-150 regulates high glucose-induced cardiomyocyte hypertrophy by targeting the transcriptional co-activator p300. Exp Cell Res. 2012; 319(3):173-84. DOI: 10.1016/j.yexcr.2012.11.015. View

Cui L, Guo X, Qi Y, Qi X, Ge Y, Shi Z . Identification of microRNAs involved in the host response to enterovirus 71 infection by a deep sequencing approach. J Biomed Biotechnol. 2010; 2010:425939. PMC: 2896697. DOI: 10.1155/2010/425939. View

Forbes S, Bhamra G, Bamford S, Dawson E, Kok C, Clements J . The Catalogue of Somatic Mutations in Cancer (COSMIC). Curr Protoc Hum Genet. 2008; Chapter 10:Unit 10.11. PMC: 2705836. DOI: 10.1002/0471142905.hg1011s57. View

Suryanarayana T, Uppala J, Garapati U . Interaction of cytochrome c with tRNA and other polynucleotides. Mol Biol Rep. 2012; 39(9):9187-91. DOI: 10.1007/s11033-012-1791-9. View

Fu H, Feng J, Liu Q, Sun F, Tie Y, Zhu J . Stress induces tRNA cleavage by angiogenin in mammalian cells. FEBS Lett. 2008; 583(2):437-42. DOI: 10.1016/j.febslet.2008.12.043. View

Reed J, Sim S, Wolin S, Clancy R, Buyon J . Ro60 requires Y3 RNA for cell surface exposure and inflammation associated with cardiac manifestations of neonatal lupus. J Immunol. 2013; 191(1):110-6. PMC: 3708308. DOI: 10.4049/jimmunol.1202849. View

Zhang A, Langley A, Christov C, Kheir E, Shafee T, Gardiner T . Dynamic interaction of Y RNAs with chromatin and initiation proteins during human DNA replication. J Cell Sci. 2011; 124(Pt 12):2058-69. PMC: 3104036. DOI: 10.1242/jcs.086561. View

10.

. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015; 517(7536):576-82. PMC: 4311405. DOI: 10.1038/nature14129. View

11.

Dhahbi J, Spindler S, Atamna H, Boffelli D, Martin D . Deep Sequencing of Serum Small RNAs Identifies Patterns of 5' tRNA Half and YRNA Fragment Expression Associated with Breast Cancer. Biomark Cancer. 2014; 6:37-47. PMC: 4260766. DOI: 10.4137/BIC.S20764. View

12.

Clancy R, Alvarez D, Komissarova E, Barrat F, Swartz J, Buyon J . Ro60-associated single-stranded RNA links inflammation with fetal cardiac fibrosis via ligation of TLRs: a novel pathway to autoimmune-associated heart block. J Immunol. 2010; 184(4):2148-55. PMC: 3551297. DOI: 10.4049/jimmunol.0902248. View

13.

Feng J, Yang Y, Zhang P, Wang F, Ma Y, Qin H . miR-150 functions as a tumour suppressor in human colorectal cancer by targeting c-Myb. J Cell Mol Med. 2014; 18(10):2125-34. PMC: 4244026. DOI: 10.1111/jcmm.12398. View

14.

Li T, Xie J, Shen C, Cheng D, Shi Y, Wu Z . miR-150-5p inhibits hepatoma cell migration and invasion by targeting MMP14. PLoS One. 2014; 9(12):e115577. PMC: 4280173. DOI: 10.1371/journal.pone.0115577. View

15.

Kozomara A, Griffiths-Jones S . miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 2013; 42(Database issue):D68-73. PMC: 3965103. DOI: 10.1093/nar/gkt1181. View

16.

Hou Y, Yang X . Regulation of cell death by transfer RNA. Antioxid Redox Signal. 2013; 19(6):583-94. PMC: 3717200. DOI: 10.1089/ars.2012.5171. View

17.

Langmead B, Trapnell C, Pop M, Salzberg S . Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009; 10(3):R25. PMC: 2690996. DOI: 10.1186/gb-2009-10-3-r25. View

18.

Martinez I, Cazalla D, Almstead L, Steitz J, DiMaio D . miR-29 and miR-30 regulate B-Myb expression during cellular senescence. Proc Natl Acad Sci U S A. 2010; 108(2):522-7. PMC: 3021067. DOI: 10.1073/pnas.1017346108. View

19.

Saikia M, Jobava R, Parisien M, Putnam A, Krokowski D, Gao X . Angiogenin-cleaved tRNA halves interact with cytochrome c, protecting cells from apoptosis during osmotic stress. Mol Cell Biol. 2014; 34(13):2450-63. PMC: 4054315. DOI: 10.1128/MCB.00136-14. View

20.

Rutjes S, van der Heijden A, Utz P, van Venrooij W, Pruijn G . Rapid nucleolytic degradation of the small cytoplasmic Y RNAs during apoptosis. J Biol Chem. 1999; 274(35):24799-807. DOI: 10.1074/jbc.274.35.24799. View